Laboratory Corp. of America Holdings (LabCorp) was founded in 1971 and is headquartered in Burlington, North Carolina. The company primarily provides comprehensive clinical laboratory services, offering testing and diagnostic solutions to healthcare providers, patients, and pharmaceutical companies.
| Bond Name | Country | Maturity | Coupon(%) | |
|---|---|---|---|---|
| LH 1.55% 2026-06-01 USDLaboratory Corp. Of America Holdings | United States | 2026-06-01 | 1.550 | 4.28 |
| LH 2.70% 2031-06-01 USDLaboratory Corp. Of America Holdings | United States | 2031-06-01 | 2.700 | 4.41 |
| LH 2.95% 2029-12-01 USDLaboratory Corp. Of America Holdings | United States | 2029-12-01 | 2.950 | 4.29 |
| LH 3.60% 2025-02-01 USDLaboratory Corp. Of America Holdings | United States | 2025-02-01 | 3.600 | 17.71 |
| LH 3.60% 2027-09-01 USDLaboratory Corp. Of America Holdings | United States | 2027-09-01 | 3.600 | 3.99 |
| LH 4.35% 2030-04-01 USDLaboratory Corp. Of America Holdings | United States | 2030-04-01 | 4.350 | 4.29 |
| LH 4.55% 2032-04-01 USDLaboratory Corp. Of America Holdings | United States | 2032-04-01 | 4.550 | 4.57 |
| LH 4.70% 2045-02-01 USDLaboratory Corp. Of America Holdings | United States | 2045-02-01 | 4.700 | 5.54 |
| LH 4.80% 2034-10-01 USDLaboratory Corp. Of America Holdings | United States | 2034-10-01 | 4.800 | 4.87 |
Company overview and issue history are AI generated, and should not be cited or relied on without verification.
LabCorp first began issuing bonds in the late 1990s, with significant issuances occurring to fund acquisitions and capital expenditures. One noteworthy issuance was a $1 billion bond in 2018 to finance the acquisition of Covance, enhancing their portfolio in drug development services. Currently, LabCorp's bonds yield around 4.5%, competitive with industry averages, and feature attractive terms that appeal to institutional investors, contributing to their financial stability and growth strategy.